Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × penpulimab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Ifosfamide 29 Methotrexate 27 Doxorubicin 25 Cyclophosphamide 23 Cisplatin 21 Etoposide 16 Filgrastim 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 11 Temozolomide 9 Specimen Handling 9 fludarabine 8 X-Rays 8 Nivolumab 8 Neoadjuvant Therapy 8 Granulocyte Colony-Stimulating Factor 8 Carboplatin 8 apatinib 7 Zoledronic Acid 7 Sirolimus 7 Radiotherapy 7 Phantoms, Imaging 7 Irinotecan 7 Drug Therapy 7 Docetaxel 7 Biopsy 7 mifamurtide 6 cabozantinib 6 Vincristine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡